BOROSCI · Borosil Scientific Ltd · Personal & Household Prods.
BOROSCI · Borosil Scientific Ltd · Personal & Household Prods.
As of 05 Nov close
52-week range
40.4% below 52-week high
52-week range: as of 05 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old
Revenue (latest Q)
₹107 Cr
Revenue YoY
PAT YoY
+205.1%
Operating margin
Revenue, last 8 quarters
P/E (TTM)
P/B
2.9
P/S (TTM)
2.3
Sector P/E
42
Dividend yield
0.0%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| BOROSCI (this stock) | 35.6 | 2.9 | +9.0% | +9.8% | 0.02 | 0.0% |
| Hindustan Unilever | 47.5 | 10.3 | +22.5% | +30.7% | 0.03 | +2.1% |
| Marico | 57.4 | 62.3 | +13.2% | +44.9% | 0.13 | +0.5% |
| Godrej Consumer Products | 54 | 36.4 | +12.2% | +15.1% | 0.35 | +2.3% |
Promoter
rising 2q
FII
rising 1q
MF
0.01% (0.00pp)
stable
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
No bulk/block deals in the last 12 months.
News timeline
No related news.
Concalls & investor presentations
AI-generatedNo concall transcripts or investor presentations recorded yet.
AI Summary of Annual Report
AI-generatedBorosil Scientific Limited reported a market capitalization of ₹1,086.68 crores as of March 31, 2025, with no material regulatory penalties, defaults, or liquidity issues noted. The company maintained compliance with corporate governance standards, including an unmodified audit opinion on its financial statements. No significant legal or regulatory actions were disclosed, and there were no defaults on borrowings or deposits. The company’s financial performance and strategic outlook were not detailed in the provided evidence.
- No material regulatory penalties, defaults, or liquidity issues were disclosed.
- The company maintained compliance with corporate governance standards and received an unmodified audit opinion.
- No significant legal or regulatory actions were noted during the year under review.
- The company has not been declared a wilful defaulter by any financial institution or bank.
Key takeaway: Borosil Scientific Limited appears to have maintained compliance and operational stability without major financial or regulatory issues in FY2024-25.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
No item of a kind that needs attention was stored for this company.
Contingent Liability
3 occurrencesRecent (last 12 months)
The company has contingent liabilities including disputed liabilities in appeal related to Goods and Service Tax and others, and guarantees, including bank guarantees of ₹73.96 lakhs as at 31st March, 2025, with ₹2.76 lakhs transferred to the company from Borosil Limited during the year.
Earlier (1-3 years ago)
The company has recognized expenses of ₹16.99 lakhs related to equity settled share-based payment transactions, shown as payable to Borosil Limited under current financial liabilities.
The company has disputed liabilities in appeal related to Goods and Service Tax and guarantees, including bank guarantees of ₹5.90 lakhs in the name of the demerged company, Borosil Limited, which are being transferred to the company.
Related-Party Transaction
3 occurrencesRecent (last 12 months)
Borosil Scientific Limited has approved related party transactions with Borosil Limited, including the sale of glassware products up to ₹100 crores for FY 2024-25, with increases in subsequent years.
Earlier (1-3 years ago)
Borosil Limited is a related party of the Company. The Members approved material related party transactions including sale of glassware products to BL for ₹100 crores in FY 2024-25, with increases in subsequent years.
The company approved modification in Related Party Transactions relating to sale/purchase of products to/from Borosil Limited.